N/A
N=62
Diagnostic Use of Lung Ultrasound for Suspected Pneumonia in Nepal
Pneumonia
Bottom Line
View on ClinicalTrials.gov: NCT02949141 ↗Enrolled (actual)
62
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Diagnosis of Pneumonia — 40; 32; 4; 12 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lung Ultrasound (Device); Chest X-ray (Device); Chest Computed Tomography (CT) (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Patan Academy of Health Sciences
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diagnosis of Pneumonia |
40; 32; 4; 12; 7; 9 | — |
Summary
This study is designed to evaluate the use of lung ultrasound compared to chest x-ray to diagnose pneumonia in Nepal. Given the ease, portability, and relative ease of teaching ultrasound, this would be potential technology available for many clinicians throughout Nepal to use for adult and pediatric patients presenting with suspected pneumonia. This would be especially useful in remote areas where clinicians have limited access to x-rays. Despite its utility, use of ultrasound to diagnose pneumonia in resource-limited settings like Nepal has not yet been studied. Therefore, this study is designed as a prospective, clinical diagnostic study to evaluate patients presenting with suspected pneumonia using diagnostic imaging of beside ultrasound compared with chest x-ray using computed tomography as the gold standard for diagnosis of pneumonia.
Eligibility Criteria
Inclusion Criteria
- Patients presenting to the Emergency Department at Patan Hospital age 18 or older with suspected signs of pneumonia with at least three of the following: temperature greater than 38 or history of fever, cough, dyspnea, heart rate higher than 100 beats per minute, or oxygen saturation lower than 92%.
Exclusion Criteria
- Children will be excluded from the study. Also, ultrasound studies completed by physicians not trained in lung ultrasound will not be included.
Data sourced from ClinicalTrials.gov (NCT02949141). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.